Ulrik Lytt RahbekAssoc. VP, Innovation & Portfolio Execution in Nucleic Acid Research (N.A.R.) at Novo NordiskSpeaker
Agenda Sessions
Keynote Panel: RNA 2026 & Beyond – The Geopolitical Impact on RNA Development in Europe
, 15:55View Session
